ADAPTIVE PHAGE THERAPEUTICS, INC.

Profile

Company Names

ADAPTIVE PHAGE THERAPEUTICS, INC.

Addresses

708 QUINCE ORCHARD ROAD, GAITHERSBURG, MD 20878

708 QUINCE ORCHARD RD, SUITE 205, GAITHERSBURG, MD 20878

22 FIRSTFIELD ROAD, SUITE 125, GAITHERSBURG, MD 20878

7211 EXFAIR ROAD, BETHESDA, MD 20814

Phone Numbers

8449720500
844-972-0500
240-899-2532
2408992532

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$46,371,387.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-05-25 
$11,999,999.00 
$30,000,000.00 
$18,000,001.00 
Equity 
4
2021-05-07 
$23,262,000.00 
$53,262,037.00 
$30,000,037.00 
Equity 
3
2020-06-05 
$3,350,000.00 
$7,000,000.00 
$3,650,000.00 
Debt 
2
2018-01-24 
$6,994,388.00 
$7,000,000.00 
$5,612.00 
Debt 
1
2017-02-02 
$765,000.00 
$3,000,000.00 
$2,235,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUBHENDU 
 
BASU 
EXECUTIVE OFFICER
ADAPTIVE PHAGE THERAPEUTICS, INC.
JESSE 
 
GOODMAN 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.   |  BIOMX INC.
IAN 
 
HARDY 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
MARTIN 
 
HEIDECKER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  SENTIEN BIOTECHNOLOGIES, INC.   |  TILOS THERAPEUTICS, INC.   |  ABEXXA BIOLOGICS, INC.   |  ARMAGEN, INC.   |  RGENTA THERAPEUTICS, INC.   |  VENATORX PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  ELION THERAPEUTICS, INC.
JANA 
 
JENSEN 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
EVAN 
 
LOH 
DIRECTOR
PARATEK PHARMACEUTICALS INC   |  N30 PHARMACEUTICALS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.
RAYMOND 
 
MARTZ 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
RAYMOND 
L. 
MARTZ 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
CARL 
 
MERRIL 
EXECUTIVE OFFICER, DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
CARL 
R. 
MERRIL 
EXECUTIVE OFFICER, DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
GREGORY 
 
MERRIL 
EXECUTIVE OFFICER, DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.   |  BIOMX INC.
GREGORY 
L. 
MERRIL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ADAPTIVE PHAGE THERAPEUTICS, INC.
GREGORY 
LOUIS 
MERRIL 
EXECUTIVE OFFICER, DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
WILLIAM 
 
MUTRYN 
DIRECTOR
BLUESTONE INVESTMENT PARTNERS II, LP   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INTREPID SOLUTIONS + SERVICES HOLDINGS, LLC   |  CBEYONDATA HOLDINGS, LLC   |  PRECISE SYSTEMS HOLDINGS, LLC   |  QUALIS HOLDINGS, LLC
MICHAEL 
 
ORNDORFF 
EXECUTIVE OFFICER
SENTRINSIC LLC   |  SENTRINSIC, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-25 
2021-05-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-07 
2020-08-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-06-05 
2020-06-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-06-05 
2019-11-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-24 
2018-06-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-24 
2017-04-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#